Serum OX40 ligand as a biochemical regulator of Th2-dominant immune activation in asthma: An integrated cytokine network analysis
Journal of Medical Biochemistry · 2026 · 45 (6) · 1295-1306
DOI: 10.5937/jomb0-64381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Biochemistry, 2026. Verfasst von Ziyi Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Jiaxing University, Department of Pulmonary and Critical Care Medicine, Jiaxing, Zhejiang, China. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Asthma is characterized by complex immune dysregulation involving coordinated cytokine and chemokine networks. OX40 ligand (OX40L), a key T-cell co-stimulatory molecule, has been implicated in Th2-mediated inflammation; however, its serum-level biochemical interactions with immune activation pathways in asthma remain incompletely defined.
Methods
In this cross-sectional study, serum OX40L and immune activation-related factors were quantified in 82 patients with asthma and 40 healthy controls. Multiplex cytokine analysis was performed to measure Th2-, Th17-, proand anti-inflammatory mediators, along with chemokines and total IgE. Lung function indices were assessed by spirometry. Correlation analysis and multivariable linear regression were applied to identify immune factors independently associated with serum OX40L levels.
Results
Serum OX40L concentrations were significantly elevated in asthma patients compared with controls and increased progressively with disease severity (all P<0.001). OX40L exhibited strong positive correlations with Th2-associated cytokines, particularly interleukin-5 (IL-5; r=0.75, adjusted P<0.001), and chemokines, while showing a significant inverse association with the anti-inflammatory cytokine IL-10. OX40L levels were also negatively correlated with forced expiratory volume in one second (FEV1%pred; r=-0.72, P<0.001). Multivariable regression identified IL-5 (b=0.35), FEV1%pred (b=-0.28), and annual exacerbation frequency (b=0.22) as independent biochemical determinants of serum OX40L, collectively explaining 68.3% of its variance.
Conclusion
Serum OX40L is closely integrated within the Th2-dominant immune activation network in asthma and reflects both immune imbalance and functional airway impairment. These findings support OX40L as a biochemically relevant indicator of immune activation intensity and highlight its potential association with cytokine-driven immune regulatory pathways in asthma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Affiliated Hospital of Jiaxing University, Department of Pulmonary and Critical Care Medicine, Jiaxing, Zhejiang, China.
Zitieren
APA
Zhu, Z., & Li, S. (2026). Serum OX40 ligand as a biochemical regulator of Th2-dominant immune activation in asthma: An integrated cytokine network analysis. Journal of Medical Biochemistry, 45(6), 1295-1306. https://doi.org/10.5937/jomb0-64381
Vancouver
Zhu Z, Li S. Serum OX40 ligand as a biochemical regulator of Th2-dominant immune activation in asthma: An integrated cytokine network analysis. Journal of Medical Biochemistry. 2026;45(6):1295-1306. doi:10.5937/jomb0-64381
BibTeX
@article{Zhu2026,
author = {Zhu, Ziyi and Li, Shumin},
title = {Serum OX40 ligand as a biochemical regulator of Th2-dominant immune activation in asthma: An integrated cytokine network analysis},
journal = {Journal of Medical Biochemistry},
year = {2026},
volume = {45},
number = {6},
pages = {1295--1306},
doi = {10.5937/jomb0-64381}
}
EUVIMED